.Merck trumps revenues assumptions, increases sales expectation on powerful need for best drugs like Keytruda CNBCMerck & Co. (MRK US) Trumps Revenue Forecasts as Keytruda Sales Surge BloombergMerck Sell: Pharma Giant Posts Strong Results, But Overview Tumbles Short Entrepreneur's Organization DailyMerck Announces Second-Quarter 2024 Financial Results Yahoo FinanceMerck defeats income and also sales expectations amidst Keytruda advantage, however gives mixed full-year outlook MarketWatch.